FAT TISSUE INCREASED side effect
What is FAT TISSUE INCREASED ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
FAT TISSUE INCREASED and Recently Reported Side Effects
FAT TISSUE INCREASED and 15 most Active Side Effect polls
FAT TISSUE INCREASED and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with FAT TISSUE INCREASED
ACTOS AVANDIA CELEBREX CHLORTHALIDONE COMBIVIR CYCLOSPORINE EVISTA HUMIRA KALETRA LAMIVUDINE LYRICA MEDROL REBIF ZYPREXACyclosporine Side Effects Report #5657375-5
Health Professional from GERMANY reported CYCLOSPORINE problem on Feb 29, 2008. Female patient, 49 years of age, was diagnosed with liver transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, fluid retention, intra-abdominal haemorrhage, laparotomy, lipomatosis, liver disorder, liver transplant rejection, transaminases increased, weight increased, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with TACROLIMUS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, PREDNISOLONE. Patient recovered.
Humira Side Effects Report #5666802-9
HUMIRA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 31, 2007. Male patient, weighting 170.2 lb, was diagnosed with crohn's disease and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, injection site erythema, injection site pruritus, swelling face, weight increased, . HUMIRA dosage: unknown. Patient recovered.
Rebif Side Effects Report #5510587-3
Consumer or non-health professional from UNITED STATES reported REBIF problem on Oct 26, 2007. Female patient, 52 years of age, weighting 130.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, gastritis, hot flush, mass, paraesthesia, uterine leiomyoma, . REBIF dosage: unknown. During the same period patient was treated with LEXAPRO. Patient recovered.
Lyrica Side Effects Report #5478985-4
LYRICA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 24, 2007. Female patient, weighting 141.1 lb, was diagnosed with neuralgia and was treated with LYRICA. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, increased appetite, muscle atrophy, renal function test abnormal, weight increased, . LYRICA dosage: unknown. During the same period patient was treated with ULTRAM. Patient recovered.
Chlorthalidone Side Effects Report #5418363-7
Physician from SWITZERLAND reported CHLORTHALIDONE problem on Aug 15, 2007. Male patient, weighting 167.6 lb, was diagnosed with prostate cancer and was treated with CHLORTHALIDONE. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, . CHLORTHALIDONE dosage: unknown. During the same period patient was treated with PHENPROCOUMON, AMIODARONE HYDROCHLORIDE, ELIGARD. Patient recovered.
Medrol Side Effects Report #5383262-6
MEDROL problem was reported by a Physician from UNITED STATES on June 29, 2007. Male patient, weighting 158.1 lb, was diagnosed with tendonitis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, fluid retention, gynaecomastia, swelling, . MEDROL dosage: unknown. During the same period patient was treated with VITAMIN. Patient recovered.
Avandia Side Effects Report #5393484-6
Consumer or non-health professional from UNITED STATES reported AVANDIA problem on June 20, 2006. Female patient, 68 years of age, was treated with AVANDIA. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, musculoskeletal discomfort, weight decreased, . AVANDIA dosage: 4MG PER DAY. During the same period patient was treated with FUROSEMIDE, MIACALCIN, WARFARIN, CALCITRIOL, METOPROLOL TARTRATE, COZAAR, ZOCOR, ZETIA. Patient recovered.
Evista Side Effects Report #5395650-2
EVISTA problem was reported by a Consumer or non-health professional from UNITED STATES on July 17, 2007. Female patient was diagnosed with osteoporosis and was treated with EVISTA. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, non-cardiac chest pain, pleurisy, . EVISTA dosage: 60 MG, UNK. During the same period patient was treated with ROFECOXIB. Patient recovered.
Evista Side Effects Report #5396166-X
Consumer or non-health professional from UNITED STATES reported EVISTA problem on July 17, 2007. Female patient was diagnosed with osteoporosis and was treated with EVISTA. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, non-cardiac chest pain, pleurisy, . EVISTA dosage: 60 MG, UNK. During the same period patient was treated with ROFECOXIB. Patient recovered.
Medrol Side Effects Report #5383262-6
MEDROL problem was reported by a Physician from UNITED STATES on June 29, 2007. Male patient, weighting 158.1 lb, was diagnosed with tendonitis and was treated with MEDROL. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, fluid retention, gynaecomastia, swelling, . MEDROL dosage: unknown. During the same period patient was treated with VITAMIN. Patient recovered.
Avandia Side Effects Report #5393484-6
Consumer or non-health professional from UNITED STATES reported AVANDIA problem on June 20, 2006. Female patient, 68 years of age, was treated with AVANDIA. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, musculoskeletal discomfort, weight decreased, . AVANDIA dosage: 4MG PER DAY. During the same period patient was treated with FUROSEMIDE, MIACALCIN, WARFARIN, CALCITRIOL, METOPROLOL TARTRATE, COZAAR, ZOCOR, ZETIA. Patient recovered.
Evista Side Effects Report #5395650-2
EVISTA problem was reported by a Consumer or non-health professional from UNITED STATES on July 17, 2007. Female patient was diagnosed with osteoporosis and was treated with EVISTA. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, non-cardiac chest pain, pleurisy, . EVISTA dosage: 60 MG, UNK. During the same period patient was treated with ROFECOXIB. Patient recovered.
Evista Side Effects Report #5396166-X
Consumer or non-health professional from UNITED STATES reported EVISTA problem on July 17, 2007. Female patient was diagnosed with osteoporosis and was treated with EVISTA. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, non-cardiac chest pain, pleurisy, . EVISTA dosage: 60 MG, UNK. During the same period patient was treated with ROFECOXIB. Patient recovered.
Lyrica Side Effects Report #5782600-X
LYRICA problem was reported by a Consumer or non-health professional from UNITED STATES on June 11, 2008. Male patient, weighting 220.0 lb, was diagnosed with neuropathy peripheral and was treated with LYRICA. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, waist circumference increased, . LYRICA dosage: unknown. Patient recovered.
Avandia Side Effects Report #5733247-2
Consumer or non-health professional from UNITED STATES reported AVANDIA problem on May 05, 2008. Female patient, 61 years of age, was treated with AVANDIA. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, foot fracture, gait disturbance, pain, weight increased, . AVANDIA dosage: 4MG PER DAY. During the same period patient was treated with METFORMIN, GEMFIBROZIL, CRESTOR, ZETIA, EVISTA. Patient recovered.
Combivir Side Effects Report #5740620-5
COMBIVIR problem was reported by a Physician from ZIMBABWE on May 14, 2008. Female patient, 38 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, lipohypertrophy, . COMBIVIR dosage: unknown. During the same period patient was treated with TENOFOVIR. Patient recovered.
Evista Side Effects Report #5357245-6
Consumer or non-health professional from UNITED STATES reported EVISTA problem on June 04, 2007. Female patient was diagnosed with osteoporosis and was treated with EVISTA. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, mastectomy, non-cardiac chest pain, pleurisy, . EVISTA dosage: 60 MG, UNK. During the same period patient was treated with ROFECOXIB. Patient recovered.
Avandia Side Effects Report #5369509-0
AVANDIA problem was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2007. Female patient, 61 years of age, was treated with AVANDIA. After drug was administered, patient experienced the following problems/side effects: fat tissue increased, foot fracture, gait disturbance, pain, weight increased, . AVANDIA dosage: 4MG PER DAY. During the same period patient was treated with METFORMIN, GEMFIBROZIL, CRESTOR, ZETIA, EVISTA. Patient recovered.
Lamivudine Side Effects Report #5692273-2
Consumer or non-health professional from ITALY reported LAMIVUDINE problem on Mar 17, 2008. Male patient, 40 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: blood triglycerides increased, fat tissue increased, hypertensive crisis, left ventricular hypertrophy, lipoatrophy, renal failure, reversible posterior leukoencephalopathy syndrome, . LAMIVUDINE dosage: unknown. During the same period patient was treated with RETROVIR, STAVUDINE, INDINIVIR SULPHATE, FENOFIBRATE. Patient was hospitalized. Patient recovered.
Combivir Side Effects Report #5606684-4
COMBIVIR problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2007. Female patient, 52 years of age, weighting 168.4 lb, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: depressed mood, fat tissue increased, lipoatrophy, weight decreased, . COMBIVIR dosage: unknown. During the same period patient was treated with KALETRA. Patient recovered.
Kaletra Side Effects Report #5510098-5
Physician from UNITED STATES reported KALETRA problem on Aug 28, 2007. Female patient, weighting 168.3 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: depressed mood, fat tissue increased, lipoatrophy, weight decreased, . KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient recovered.
Actos Side Effects Report #5401910-9
ACTOS problem was reported by a Consumer or non-health professional from AUSTRALIA on July 17, 2007. Female patient was diagnosed with type 2 diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, fat tissue increased, foot fracture, multiple fractures, . ACTOS dosage: 15 MG (15 MG, 1 IN 1 D), PER ORAL;40 MG (40 MG, 1 IN 1 D), PER ORAL. During the same period patient was treated with METFORMIN, WARFARIN, DIGOXIN, LIPITOR. Patient was hospitalized. Patient recovered.
Actos Side Effects Report #5401910-9
Consumer or non-health professional from AUSTRALIA reported ACTOS problem on July 17, 2007. Female patient was diagnosed with type 2 diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, fat tissue increased, foot fracture, multiple fractures, . ACTOS dosage: 15 MG (15 MG, 1 IN 1 D), PER ORAL;40 MG (40 MG, 1 IN 1 D), PER ORAL. During the same period patient was treated with METFORMIN, WARFARIN, DIGOXIN, LIPITOR. Patient was hospitalized. Patient recovered.
Humira Side Effects Report #5665312-2
HUMIRA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 01, 2008. Female patient, weighting 175.2 lb, was diagnosed with rheumatoid arthritis, hypertension and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: accidental exposure, fat tissue increased, rheumatoid arthritis, . HUMIRA dosage: unknown. During the same period patient was treated with LISINOPRIL, DIURETICS, HYDROCHLOROTHIAZIDE. Patient recovered.
Celebrex Side Effects Report #5645779-6
Physician from UNITED STATES reported CELEBREX problem on Feb 22, 2008. Female patient, weighting 91.93 lb, was diagnosed with osteoarthritis, intervertebral disc protrusion, palpitations, migraine and was treated with CELEBREX. After drug was administered, patient experienced the following problems/side effects: angioedema, fat tissue increased, stevens-johnson syndrome, weight decreased, weight increased, . CELEBREX dosage: unknown. During the same period patient was treated with BEXTRA, INDERAL LA, COMBIPATCH, IMITREX. Patient recovered.
Humira Side Effects Report #5768247-X
HUMIRA problem was reported by a Consumer or non-health professional from UNITED STATES on May 13, 2008. Female patient, weighting 123.1 lb, was diagnosed with psoriatic arthropathy, osteoporosis, glaucoma, vitamin supplementation and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: abdominal distension, dry skin, fat tissue increased, injection site irritation, injection site pain, joint swelling, muscular weakness, oedema peripheral, pruritus, . HUMIRA dosage: unknown. During the same period patient was treated with ESTROGENIC SUBSTANCE, RISEDRONATE, COSOPT, DULOXETINE HYDROCHLORIDE, ESTRADIOL, IBANDRONATE, ERGOCALCIFEROL. Patient recovered.
Zyprexa Side Effects Report #5356959-1
Consumer or non-health professional from UNITED STATES reported ZYPREXA problem on Mar 14, 2007. Female patient, 43 years of age, weighting 173.1 lb, was diagnosed with mood swings and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, dyspnoea, fat tissue increased, lyme disease, oedema peripheral, weight increased, . ZYPREXA dosage: 5 MG, ORAL. During the same period patient was treated with ZYPREXA ZYDIS, DEPAKOTE, PROTONIX, PROMETRIUM, ATIVAN, DOXICLAT. Patient recovered.